Onkos Surgical raises $15M Series C
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopedic procedures based in Parsippany, announced Wednesday that it has raised $15 million in Series C funding from its existing investor syndicate. Read More →
Onkos Surgical wins FDA clearance for BioGrip 3D-Printed implant
Onkos Surgical today announced that it received FDA 510(k) clearance for its BioGrip 3D-printed implant technology. Read More →
Onkos Surgical® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS™ Proximal Tibia with BioGrip™ technology
Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology. Read More →
Onkos Surgical raises $7.6m
Surgical oncology device developer Onkos Surgical filed an SEC Form D to confirm the sale of nearly $7.6 million in equity. Earlier this year, the company announced the launch of its GenVie Magnesium Bone Scaffold. The magnesium-based bone void filler with osteoconductive and high compression strength attributes to promote bone repair and regeneration.
Read More →
Onkos Surgical® announces the launch of GenVie™, a novel Magnesium Bone Scaffolding technology
PARSIPPANY, N.J., Feb. 6, 2020 /PRNewswire/ — Onkos Surgical® is pleased to announce the launch of GenVie™ Magnesium Bone Scaffold, a novel biologic technology that further expands Onkos’ reach in complex limb salvage procedures. GenVie is the first 510(k) cleared magnesium-based bone void... Read More →
Onkos Surgical Partners With Integrum
Onkos Surgical, Inc. a leader in the field of musculoskeletal oncology and personalized orthopaedics announced today a multi-year agreement with Integrum AB (INTEG B: Nasdaq First North exchange). The collaboration between companies will commence immediately and will be focused on... Read More →
3D Systems Gains FDA Clearance for VSP Orthopaedics 3D Surgical Pre-Planning Solution
3D printing company 3D Systems has just announced 510(k) clearance from the Food and Drug Administration (FDA) for their VSP Orthopaedics solution. This development will further increase solutions offered in their VSP approach for orthopaedics, which has already played a role in the treatment... Read More →
Bone Solutions, Onkos ink private label deal
Bone Solutions said today that it entered into a private label licensing agreement with Onkos Surgical for its OsteoCrete bone void-filling technology. Colleyville, Texas-based BSI’s OsteoCrete is an FDA 510(k)-cleared magnesium-based injectable, moldable solution designed to attaching ligaments and tendons to bone and... Read More →